From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases:
Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01)
“The goal of this opportunity is to support innovative research in humans to elucidate the role of HIV infection, including relevant host conditions or antiretroviral therapy, on metabolic and endocrine dysfunction, as well as to support innovative research delineating the pathophysiology, etiology, risk or protective factors, and potential strategies to prevent, treat, or reverse endocrine and metabolic dysfunction in HIV-infected individuals. Proposed projects must involve human subjects with HIV infection or materials or data from HIV-infected individuals. Proposed projects must also be related to the mission of the Division of Diabetes, Endocrinology, and Metabolic Diseases within NIDDK (DEM/NIDDK).”
A letter of intent is due by February 9th, 2016 and applications are due by March 9th, 2016 at 5 pm local time.
Find more information here.